Mitogen-induced defective mitosis transforms neural progenitor cells.
GBM
P53
PDGFA
kinetochore
mitosis
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
03 10 2023
03 10 2023
Historique:
pmc-release:
26
04
2024
medline:
5
10
2023
pubmed:
15
5
2023
entrez:
15
5
2023
Statut:
ppublish
Résumé
Chromosome instability (CIN) with recurrent copy number alterations is a feature of many solid tumors, including glioblastoma (GBM), yet the genes that regulate cell division are rarely mutated in cancers. Here, we show that the brain-abundant mitogen, platelet-derived growth factor-A (PDGFA) fails to induce the expression of kinetochore and spindle assembly checkpoint genes leading to defective mitosis in neural progenitor cells (NPCs). Using a recently reported in vitro model of the initiation of high-grade gliomas from murine NPCs, we investigated the immediate effects of PDGFA exposure on the nuclear and mitotic phenotypes and patterns of gene and protein expression in NPCs, a putative GBM cell of origin. NPCs divided abnormally in defined media containing PDGFA with P53-dependent effects. In wild-type cells, defective mitosis was associated with P53 activation and cell death, but in some null cells, defective mitosis was tolerated. Surviving cells had unstable genomes and proliferated in the presence of PDGFA accumulating random and clonal chromosomal rearrangements. The outcome of this process was a population of tumorigenic NPCs with recurrent gains and losses of chromosomal regions that were syntenic to those recurrently gained and lost in human GBM. By stimulating proliferation without setting the stage for successful mitosis, PDGFA-transformed NPCs lacking P53 function. Our work describes a mechanism of transformation of NPCs by a brain-associated mitogen, raising the possibility that the unique genomic architecture of GBM is an adaptation to defective mitosis that ensures the survival of affected cells.
Sections du résumé
BACKGROUND
Chromosome instability (CIN) with recurrent copy number alterations is a feature of many solid tumors, including glioblastoma (GBM), yet the genes that regulate cell division are rarely mutated in cancers. Here, we show that the brain-abundant mitogen, platelet-derived growth factor-A (PDGFA) fails to induce the expression of kinetochore and spindle assembly checkpoint genes leading to defective mitosis in neural progenitor cells (NPCs).
METHODS
Using a recently reported in vitro model of the initiation of high-grade gliomas from murine NPCs, we investigated the immediate effects of PDGFA exposure on the nuclear and mitotic phenotypes and patterns of gene and protein expression in NPCs, a putative GBM cell of origin.
RESULTS
NPCs divided abnormally in defined media containing PDGFA with P53-dependent effects. In wild-type cells, defective mitosis was associated with P53 activation and cell death, but in some null cells, defective mitosis was tolerated. Surviving cells had unstable genomes and proliferated in the presence of PDGFA accumulating random and clonal chromosomal rearrangements. The outcome of this process was a population of tumorigenic NPCs with recurrent gains and losses of chromosomal regions that were syntenic to those recurrently gained and lost in human GBM. By stimulating proliferation without setting the stage for successful mitosis, PDGFA-transformed NPCs lacking P53 function.
CONCLUSIONS
Our work describes a mechanism of transformation of NPCs by a brain-associated mitogen, raising the possibility that the unique genomic architecture of GBM is an adaptation to defective mitosis that ensures the survival of affected cells.
Identifiants
pubmed: 37186014
pii: 7143755
doi: 10.1093/neuonc/noad082
pmc: PMC10547526
doi:
Substances chimiques
Mitogens
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1763-1774Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Genes Dev. 2018 May 1;32(9-10):620-638
pubmed: 29802124
Semin Cell Dev Biol. 2021 Sep;117:62-74
pubmed: 33753005
Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221
pubmed: 35325185
Bioinformatics. 2016 Oct 1;32(19):3012-4
pubmed: 27288499
Cancer Cell. 2014 Aug 11;26(2):288-300
pubmed: 25117714
Cell. 2018 Sep 6;174(6):1347-1360
pubmed: 30193109
Science. 1992 Mar 27;255(5052):1707-10
pubmed: 1553558
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):984-9
pubmed: 26755576
Mol Cell. 2015 Nov 19;60(4):524-36
pubmed: 26590712
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
J Cell Biochem. 1991 Apr;45(4):319-26
pubmed: 2045423
Cancers (Basel). 2017 Dec 28;10(1):
pubmed: 29283387
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
JAMA. 2017 Dec 19;318(23):2306-2316
pubmed: 29260225
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
Nat Cell Biol. 2009 Jan;11(1):27-35
pubmed: 19060894
Curr Biol. 2010 Sep 28;20(18):1666-71
pubmed: 20832310
Cancer Res. 2015 Dec 1;75(23):5001-7
pubmed: 26573797
Trends Cell Biol. 2017 May;27(5):314-321
pubmed: 28188027
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Science. 1964 May 15;144(3620):809-15
pubmed: 14149391
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19098-19108
pubmed: 31471491
Neuro Oncol. 2020 Aug 17;22(8):1150-1161
pubmed: 32296841
Nat Rev Cancer. 2010 Feb;10(2):102-15
pubmed: 20094045
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Nat Commun. 2019 Jun 13;10(1):2588
pubmed: 31197172
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
PLoS One. 2018 Aug 28;13(8):e0202860
pubmed: 30153289
J Biol Chem. 1992 Sep 5;267(25):18032-9
pubmed: 1325456
J Cell Biol. 2016 Jul 18;214(2):143-53
pubmed: 27432896
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Ups J Med Sci. 2012 May;117(2):99-112
pubmed: 22509804